Gluk2 (Kar2) Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Neurons expressing glutamate ionotropic kainate receptor subunit 2 (GluK2, formerly KAR2), the predominant kainate receptor (KAR) in the mammalian brain. GluK2-containing KARs are ionotropic glutamate receptors that mediate slow excitatory neurotransmission and modulate synaptic plasticity throughout the central nervous system. [@kainate2020]
Kainate receptors are tetrameric assemblies composed of five subunits (GluK1-GluK5), with GluK2 forming homomeric or heteromeric channels that conduct Na⁺ and K⁺ currents. The GluK2 subunit determines key pharmacological and biophysical properties of the receptor complex, including gating kinetics, conductance, and sensitivity to agonists and antagonists. [@gluk2018]
Gluk2 (Kar2) Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Neurons expressing glutamate ionotropic kainate receptor subunit 2 (GluK2, formerly KAR2), the predominant kainate receptor (KAR) in the mammalian brain. GluK2-containing KARs are ionotropic glutamate receptors that mediate slow excitatory neurotransmission and modulate synaptic plasticity throughout the central nervous system. [@kainate2020]
Kainate receptors are tetrameric assemblies composed of five subunits (GluK1-GluK5), with GluK2 forming homomeric or heteromeric channels that conduct Na⁺ and K⁺ currents. The GluK2 subunit determines key pharmacological and biophysical properties of the receptor complex, including gating kinetics, conductance, and sensitivity to agonists and antagonists. [@gluk2018]
Molecular Biology and Structure
The GRIK2 gene (glutamate ionotropic kainate receptor subunit 2) encodes the GluK2 protein, which consists of: [@kainate2021]
N-terminal domain (ATD): extracellular agonist-binding domain involved in subunit assembly and allosteric modulation
Ligand-binding domain (LBD): twoushiell domains (S1 and S2) that bind glutamate and kainate
Transmembrane domain (TMD): three membrane-spanning helices (M1-M3) forming the ion channel pore
C-terminal domain (CTD): intracellular region involved in protein interactions and trafficking
GluK2 undergoes extensive alternative splicing, producing multiple isoforms with distinct trafficking properties and functional characteristics. Post-translational modifications including phosphorylation, glycosylation, and SUMOylation regulate receptor localization and function. [@kar2019]
Brain Distribution
GluK2-expressing neurons are prominently distributed in: [@gluk2020]
Hippocampus
CA3 region: Highest density of GluK2-containing KARs, particularly on mossy fiber terminals
CRISPR-based approaches to correct disease mutations
RNA interference to reduce toxic gain-of-function
Viral vector delivery to specific brain regions
Biomarkers
GRIK2 expression as potential disease biomarker
CSF levels of GluK2 in neurodegenerative disease patients
Background
The study of Gluk2 (Kar2) Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.